Retrospective Comparison of Fludarabine in Combination With Intermediate-Dose Cytarabine Versus High-Dose Cytarabine As Consolidation Therapies for Acute Myeloid Leukemia

This retrospective study compared efficacy and safety of fludarabine combined with intermediate-dose cytarabine (FA regimen) versus high-dose cytarabine (HiDAC regimen) as consolidation therapy in acute myeloid leukemia (AML) patients who achieved complete remission. Disease-free survival (DFS) and...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Wenjun, Ding, Yi, Wu, Hao, Chen, Yuhua, Lu, Huina, Chen, Chunying, Fu, Jianfei, Wang, Weiguang, Liang, Aibin, Zou, Shanhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2014
Materias:
4800
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4602804/
https://www.ncbi.nlm.nih.gov/pubmed/25501050
http://dx.doi.org/10.1097/MD.0000000000000134

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4602804/
https://www.ncbi.nlm.nih.gov/pubmed/25501050
http://dx.doi.org/10.1097/MD.0000000000000134

Ejemplares similares